Biontech introduces first modular mrna manufacturing facility to promote scalable vaccine production in africa

Mainz, germany, february 16, 2022 – biontech se (nasdaq: bntx, “biontech”) has taken a next step to improve vaccine supply in africa. the company has introduced its approach to establishing scalable vaccine production by developing and delivering turnkey mrna manufacturing facilities based on a container solution. at a high-level meeting at biontech's new manufacturing facility in marburg and at the invitation of kenup foundation, the company presented the container solution named “biontainer” to key partners.
BNTX Ratings Summary
BNTX Quant Ranking